{"id":"https://openalex.org/W7225627917","doi":"https://doi.org/10.3389/fendo.2026.1983089","title":"PI PET for response assessment during antiangiogenic TKI therapy in radioiodine-refractory differentiated thyroid cancer: evidence and research priorities","display_name":"PI PET for response assessment during antiangiogenic TKI therapy in radioiodine-refractory differentiated thyroid cancer: evidence and research priorities","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225627917","doi":"https://doi.org/10.3389/fendo.2026.1983089"},"language":"en","primary_location":{"id":"doi:10.3389/fendo.2026.1983089","doi":"https://doi.org/10.3389/fendo.2026.1983089","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1983089","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1983089/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1983089/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5150677638","display_name":"Cheng Niu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091098","display_name":"Cancer Hospital of Shantou University Medical College","ror":"https://ror.org/00a53nq42","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210091098"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cheng Niu","raw_affiliation_strings":["Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College","institution_ids":["https://openalex.org/I4210091098"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150674405","display_name":"Hongdan Yao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091098","display_name":"Cancer Hospital of Shantou University Medical College","ror":"https://ror.org/00a53nq42","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210091098"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongdan Yao","raw_affiliation_strings":["Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College","institution_ids":["https://openalex.org/I4210091098"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125269054","display_name":"Peiying Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091098","display_name":"Cancer Hospital of Shantou University Medical College","ror":"https://ror.org/00a53nq42","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210091098"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peiying Lin","raw_affiliation_strings":["Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College","institution_ids":["https://openalex.org/I4210091098"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160642212","display_name":"Zefan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091098","display_name":"Cancer Hospital of Shantou University Medical College","ror":"https://ror.org/00a53nq42","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210091098"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zefan Chen","raw_affiliation_strings":["Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College","institution_ids":["https://openalex.org/I4210091098"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088277491","display_name":"Huling Wen","orcid":"https://orcid.org/0000-0001-6317-9739","observed_orcids":["https://orcid.org/0000-0001-6317-9739"]},"institutions":[{"id":"https://openalex.org/I4210091098","display_name":"Cancer Hospital of Shantou University Medical College","ror":"https://ror.org/00a53nq42","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210091098"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Huling Wen","raw_affiliation_strings":["Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Cancer Hospital of Shantou University Medical College","institution_ids":["https://openalex.org/I4210091098"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088277491"],"corresponding_institution_ids":["https://openalex.org/I4210091098"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.06809999793767929,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibroblast-activation-protein","display_name":"fibroblast activation protein","score":0.9570000171661377},{"id":"https://openalex.org/keywords/radioiodine-refractory-thyroid-cancer","display_name":"radioiodine-refractory thyroid cancer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/antiangiogenic-tyrosine-kinase-inhibitors","display_name":"antiangiogenic tyrosine kinase inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.8550000190734863},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.871999979019165},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9350000023841858},{"id":"https://openalex.org/keywords/stromal-remodeling","display_name":"stromal remodeling","score":0.6679999828338623},{"id":"https://openalex.org/keywords/imaging-biomarkers","display_name":"imaging biomarkers","score":0.5669999718666077},{"id":"https://openalex.org/keywords/clinical-validation","display_name":"clinical validation","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8379999995231628},{"id":"https://openalex.org/C111798993","wikidata":"https://www.wikidata.org/wiki/Q21117471","display_name":"Fibroblast activation protein, alpha","level":3,"score":0.5741000175476074},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5396999716758728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48730000853538513},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.4814999997615814},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.46209999918937683},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.4602999985218048},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.44369998574256897},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41440001130104065},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.40689998865127563},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4036000072956085},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3862999975681305},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.3540000021457672},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3319000005722046},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32199999690055847},{"id":"https://openalex.org/C45664433","wikidata":"https://www.wikidata.org/wiki/Q17029420","display_name":"Imaging biomarker","level":3,"score":0.31769999861717224},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.30660000443458557},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2971000075340271},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.29670000076293945},{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.27959999442100525},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2750000059604645},{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.26840001344680786},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.25920000672340393},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2581000030040741},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2572000026702881},{"id":"https://openalex.org/C2993294228","wikidata":"https://www.wikidata.org/wiki/Q13632630","display_name":"Thyroid carcinoma","level":3,"score":0.2563999891281128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fendo.2026.1983089","doi":"https://doi.org/10.3389/fendo.2026.1983089","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1983089","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1983089/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fendo.2026.1983089","doi":"https://doi.org/10.3389/fendo.2026.1983089","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1983089","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1983089/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225627917.pdf","grobid_xml":"https://content.openalex.org/works/W7225627917.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1967792499","https://openalex.org/W2019607817","https://openalex.org/W2155263737","https://openalex.org/W2168076926","https://openalex.org/W2921110418","https://openalex.org/W2922577842","https://openalex.org/W3179200118","https://openalex.org/W3206673809","https://openalex.org/W4280538543","https://openalex.org/W4309366147","https://openalex.org/W4311024093","https://openalex.org/W4378213573","https://openalex.org/W4386253926","https://openalex.org/W4387393142","https://openalex.org/W4388211438","https://openalex.org/W4390686043","https://openalex.org/W4392362481","https://openalex.org/W4400587783","https://openalex.org/W4408846251","https://openalex.org/W4409241951","https://openalex.org/W4417117723","https://openalex.org/W7124470423","https://openalex.org/W7160294495","https://openalex.org/W7163378066","https://openalex.org/W7172119968","https://openalex.org/W7208809445"],"related_works":["https://openalex.org/W7160109291","https://openalex.org/W7163378066","https://openalex.org/W4409241951","https://openalex.org/W2796043744","https://openalex.org/W4390686043","https://openalex.org/W3165564948","https://openalex.org/W4400279574","https://openalex.org/W7203726030","https://openalex.org/W4405219629","https://openalex.org/W3206673809"],"abstract_inverted_index":{"Radioiodine-refractory":[0],"differentiated":[1],"thyroid":[2],"cancer":[3],"(RAIR-DTC)":[4],"is":[5,76,97,155,171,251,297],"clinically":[6],"heterogeneous,":[7],"and":[8,35,109,140,184,227,268,284],"radioiodine":[9],"refractoriness":[10],"alone":[11],"does":[12],"not":[13,48,202,252],"mandate":[14],"immediate":[15,248],"systemic":[16],"therapy.":[17],"In":[18],"patients":[19],"with":[20,241],"progressive,":[21],"symptomatic,":[22],"or":[23,107,211,232,244],"high-burden":[24],"disease":[25],"receiving":[26],"antiangiogenic":[27,150,218],"tyrosine":[28],"kinase":[29],"inhibitors":[30],"(TKIs),":[31],"contrast-enhanced":[32],"computed":[33],"tomography":[34],"RECIST":[36],"remain":[37],"the":[38,55,94,191,247],"principal":[39],"tools":[40],"for":[41],"structural":[42],"response":[43,125,210],"assessment,":[44],"yet":[45],"they":[46,200],"may":[47],"fully":[49],"capture":[50],"early":[51],"treatment-related":[52],"changes":[53,197,206,279],"in":[54,78,130,153,173,198,214,234,280],"tumor":[56,222,242],"microenvironment.":[57],"Fibroblast":[58],"activation":[59,73],"protein":[60,74],"inhibitor":[61],"(FAPI)":[62],"PET":[63,85,119],"has":[64],"emerged":[65],"as":[66,90,122],"a":[67,123,158,230,257],"candidate":[68],"imaging":[69],"approach":[70],"because":[71,217],"fibroblast":[72],"(FAP)":[75],"abundant":[77],"activated":[79,91],"tumor-associated":[80],"stroma.":[81],"However,":[82],"while":[83],"FAPI":[84,118,169,196,235],"targets":[86],"FAP-expressing":[87],"tissues":[88],"(such":[89],"cancer-associated":[92],"fibroblasts),":[93],"measured":[95],"uptake":[96,170,236,276],"also":[98],"influenced":[99],"by":[100,180],"tracer":[101,176],"delivery,":[102],"ligand":[103],"kinetics,":[104],"non-malignant":[105],"fibrosis":[106],"inflammation,":[108],"acquisition":[110],"methods.":[111],"This":[112],"narrative":[113],"review":[114],"critically":[115],"evaluates":[116],"whether":[117],"can":[120],"serve":[121],"reliable":[124],"biomarker":[126],"during":[127,149],"TKI":[128,151],"therapy":[129,152,219],"RAIR-DTC,":[131,174],"examining":[132],"direct":[133,146],"clinical":[134,212,253,266,270],"data":[135],"alongside":[136],"disease-specific":[137],"diagnostic":[138],"studies":[139,189],"cross-cancer":[141,188],"longitudinal":[142,147],"evidence.":[143],"To":[144],"date,":[145],"evidence":[148],"RAIR-DTC":[154],"limited":[156],"to":[157],"single-patient":[159],"case":[160],"report":[161],"on":[162],"lenvatinib.":[163],"Broader":[164],"thyroid-specific":[165],"cohorts":[166],"confirm":[167],"that":[168,204],"common":[172],"though":[175],"performance":[177],"varies":[178],"substantially":[179],"ligand,":[181],"lesion":[182],"site,":[183],"cohort":[185],"selection.":[186],"While":[187],"demonstrate":[190],"feasibility":[192],"of":[193],"detecting":[194],"treatment-associated":[195],"humans,":[199],"do":[201],"prove":[203],"such":[205],"specifically":[207],"quantify":[208],"stromal":[209,228],"benefit":[213,287],"RAIR-DTC.":[215],"Moreover,":[216],"directly":[220],"alters":[221],"blood":[223],"flow,":[224],"vascular":[225],"permeability,":[226],"remodeling,":[229],"decrease":[231],"increase":[233],"cannot":[237],"be":[238,289],"automatically":[239],"equated":[240],"control":[243],"progression.":[245],"Therefore,":[246],"research":[249],"priority":[250],"implementation,":[254],"but":[255],"rather":[256],"staged":[258],"validation":[259,296],"process":[260],"encompassing":[261],"baseline":[262],"evaluability,":[263],"measurement":[264],"reliability,":[265],"validity,":[267],"ultimately":[269],"utility":[271],"beyond":[272],"standard":[273],"assessment.":[274],"Tracer":[275],"dynamics,":[277],"actual":[278],"tissue":[281],"FAP":[282],"expression,":[283],"true":[285],"patient":[286],"should":[288],"kept":[290],"conceptually":[291],"separate":[292],"until":[293],"prospective,":[294],"outcome-linked":[295],"achieved.":[298]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}